Intermedin1-53 Improves Atherosclerosis by Reducing Local Endothelial Damage via AMPK Signaling Pathway in Obese apoE-Deficient Mice
IMD<sub>1-53</sub> improves AS partially by reducing endothelial inflammatory and oxidative damage via AMPK signaling pathway and decreasing vascular lipid accumulation involving the improvement of lipid profiles in blood and in liver in a state of obesity.
Authors
- R.Y. Wang (ORCID: https://orcid.org/0000-0001-7386-0376)
- Haiyan Zhu (ORCID: https://orcid.org/0000-0002-1030-4601)
- Wenjuan Cao
- Ye‐Bo Zhou (ORCID: https://orcid.org/0000-0001-9465-1338)
- Leilei Chen (ORCID: https://orcid.org/0000-0002-1987-3878)
- Jin-Ling Ren
- Qing Gao (ORCID: https://orcid.org/0000-0002-5806-3974)
Institutions
- Peking University (CN)
- Jiangsu Province Hospital (CN)
- First Affiliated Hospital of Henan University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/jir.s505695
- Citations
- 1
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.35